[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Articles archive::
For Reviewers::
Contact us::
Biochemistry and Nutrition in Metabolic Diseases
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 5, Issue 4 (Quarterly 2002) ::
Feyz 2002, 5(4): 86-96 Back to browse issues page
Evaluation of clinical and paraclinical signs and drugs side-effects in patients with Tuberculosis
Hasan Afzali , Nikdokht Taghavi
, afzali_h@kaums.ac.ir
Abstract:   (13544 Views)

History and Objectives: Considering the increasing incidence of Tuberculosis and its high rate of mortality and complications, this study was carried out to evaluate the clinical and paraclinical signs and drugs complications in Loghman Hakim hospital in Tehran from 1993 to 1996.

Materials and Methods: The descriptive strategy of this study was carried out on patients with a diagnosis of Tuberculosis. In this regard, their history was taken, clinical signs were recorded and the tests Alk-Ph, SGOT, SGPT, PT, ESR, PPD, CBC, billirubin and uric acid were done until the end of study. Data for drugs side effects were analyzed using McNemar test.

Results: Out of 190 patients, 51% were male and 49% were female. Cases with an age less than 5 years had the least incidence and cases with a greater than 66 years had the highest incidence. In addition, 56.3% out of patients had pulmonary Tuberculosis. The most important clinical signs were fever (82%), cough and sputum (62.5%), nightly perspiration (20%), respiratory distress (16%) and bloody sputum (11.2%). Meanwhile, 44.2% out of them had positive smear of sputum, 32.1% had positive biopsy and for 33.6%, diagnosis was made according to clinical and X-ray findings. 90% out of the cases had normal CBC, 94% had a high CRP, 69% had a high ESR, 17% had a negative PPD and 25.8% showed an increase in SGOT and SGPT after treatment. Billirubin level also increased up to 8.4% after treatment and in 7.6% out of them there was abnormal PT after treatment.

Conclusion and Recommendations: Considering the elevated level of hepatic enzymes in patients with Tuberculosis and under treatment, especially in those with an old age, it is recommended to chose appropriate treatment according to hepatic toxicity.

Keywords: Tuberculosis, Drug side-effect, Hepatic enzymes, Clinical signs, Paraclinical findings
Full-Text [PDF 1772 kb]   (2368 Downloads)    
Type of Study: Research | Subject: General
Received: 2008/11/10 | Revised: 2008/11/10 | Published: 2002/01/15
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Afzali H, Taghavi N. Evaluation of clinical and paraclinical signs and drugs side-effects in patients with Tuberculosis . Feyz 2002; 5 (4) :86-96
URL: http://feyz.kaums.ac.ir/article-1-355-en.html

Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 5, Issue 4 (Quarterly 2002) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4645